M.D., Clinical Medicine, Shanxi Medical University. Shanxi, China B.Sc. 1987
M.D., Internal Medicine (Hematology), Shanxi Medical University. Shanxi, China. 1990
PhD., Hematology, Beijing Medical University. Beijing, China. 1999
Post-doctorate, Hematology/Oncology, Albert Einstein College of Medicine. Bronx, NY. 2002
Post-doctorate, Oncology, Georgetown University. Washington, DC. 2005
Involved in Clinical Research course for Medical students at Xavier University School of Medicine Aruba
1. The significance of DACH1 in PARP1 regulation in prostate cancer.
2.The role of DACH1 isoforms in prostate cancer.
View on Google Scholar.